Alpha Cognition Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Alpha Cognition Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-06-30 was $0.00.
- Alpha Cognition Inc. stock issued during period, value, stock options exercised for the quarter ending 2026-03-31 was $800.00.
- Alpha Cognition Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $343.28K.
- Alpha Cognition Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $364.61K.
- Alpha Cognition Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $707.88K, a 39226.89% increase from fiscal 2024.
- Alpha Cognition Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $1.80K, a 93.33% decline from fiscal 2023.
- Alpha Cognition Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $27.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $708.68K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $800.00 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $343.28K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $707.88K 10-K · filed 2026-03-31 |
| 2025-09-30 | $364.61K 10-Q · filed 2025-11-13 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.80K 10-K · filed 2026-03-31 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | |
| 2024-06-30 | $1.80K 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $16.50K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $27.00K 10-K · filed 2025-03-31 |
| 2023-06-30 | $10.50K 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |